¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary carbon dioxide excess"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • accommodative excess
    Á¶Àý°ú´Ù
  • base excess
    ¿°±â°úÀ×
  • convergence excess
    ´«¸ðÀ½°ú´Ù
  • divergence excess
    ´«¹ú¸²°ú´Ù, °³»ê°ú´Ù
  • divergence excess exotropia
    ´«¹ú¸²°ú´Ù¿Ü»ç½Ã, °³»ê°ú´Ù¿Ü»ç½Ã
  • excess
    °ú´Ù, °úÀ×
  • excess chlorine
    °úÀ׿°¼Ò
  • excess mortality
    Ãʰú»ç¸Á·ü
  • negative base excess
    ¿ª¿°±â°úÀ×
  • population excess rate
    ¸ðÁý´ÜÃʰúÀ²
  • active carbon
    Ȱ¼º½¡, Ȱ¼ºÅº
  • carbon
    ź¼Ò
  • carbon arc lamp
    ź¼Ò¾ÆÅ©µî
  • carbon disulfide
    ÀÌȲȭź¼Ò
  • carbon monoxide
    ÀÏ»êȭź¼Ò
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary polydipsia
    ¿ø¹ß¼º´ÙÀ½Áõ, ÀÏÂ÷Àû´ÙÀ½Áõ, ¿ø¹ß¼º´ÙÀ½´Ù°¥Áõ, ÀÏÂ÷Àû´ÙÀ½´Ù°¥Áõ
  • spontaneous primary peritonitis
    ¿ø¹ßº¹¸·¿°, ÀÏÂ÷º¹¸·¿°, ¿ø¹ß¹è¸·¿°, ÀÏÂ÷¹è¸·¿°
  • primary stage
    Ãʱâ
  • primary suture
    ÀÏÂ÷ºÀÇÕ
  • occult primary tumor
    Àẹ¿ø¹ßÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • convergence excess
    ´«¸ðÀ½°ú´Ù
  • excess chlorine
    °úÀ׿°¼Ò
  • divergence excess
    ´«¹ú¸²°ú´Ù
  • divergence excess exotropia
    ´«¹ú¸²°ú´Ù¿Ü»ç½Ã
  • excess
    °ú´Ù, °úÀ×
  • excess mortality
    Ãʰú»ç¸Á·ü
  • excess sludge
    °úÀ×Â±â
  • excess gas relief valve
    À׿©°¡½º¹èÃâÆÇ¸·
  • population excess rate
    ¸ðÁý´ÜÃʰúÀ²
  • active carbon
    Ȱ¼º½¡, Ȱ¼ºÅº
  • carbon
    ź¼Ò
  • carbon disulfide
    ÀÌȲȭź¼Ò
  • carbon monoxide
    ÀÏ»êȭź¼Ò
  • carbon oxysulfide
    Ȳȭº»
  • carbon tetrachloride
    »ç¿°È­Åº¼Ò
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • immunodeficiency syndrome, primary
    ÀÏÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¿ø¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
  • infection, primary
    ÀÏÂ÷°¨¿°
  • interaction, primary
    ÀÏÂ÷»óÈ£ÀÛ¿ë
  • pneumonia, primary atypical
    ¿ø¹ß¼º ºñÁ¤ÇüÆó·Å
  • premaxilla [primary palate]
    ¾ÕÀ§ÅλÀ (ÀÏÂ÷ÀÔõÀå)
  • primary
    ¿ø¹ß¼º(ê«Û¡àõ)ÀÇ
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary abdominal implantation
    ÀÏÂ÷¹è¾ÈÂø»ó
  • primary acquired cholesteatoma
    ÀÏÂ÷(¼º) ÈÄõ(¼º) ÁøÁÖÁ¾
  • primary action
    ÀÏÂ÷±â´É
  • primary action; main action
    ÁÖÀÛ¿ë, ÀÏÂ÷ÀÛ¿ë.
  • primary adaptation
    ÀÏÂ÷(¼º) ¼øÀÀ(ìéó­àõâ÷ëë).
  • primary adhesion
    ÀÏÂ÷(¼º) À¯Âø(¡­ë¨ó·).
  • primary affect hunger
    ÀÏÂ÷¼º¡¡¾ÖÁ¤°¥¸Á£®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • carbon dioxide narcosis
    ÀÌ»êȭź¼Ò È¥¼ö(ì£ß«ûù÷©áÈûçâ²)
  • carbon dioxide retention
    ź»ê°¡½ºÃàÀû.
  • carbon dioxide transport
    ÀÌ»êȭź¼Ò ¿î¹Ý(ê¡Úæ)(À̵¿,¼ö¼Û)
  • extracorporeal carbon dioxide removal =ECCO2R
    ü¿ÜÀÌ»êȭź¼Ò Á¦°Å¹ý
  • laser, carbon dioxide
    ź»ê°¡½º ÀÌ»êȭź¼Ò·¹ÀÌÀú
  • oxygen carbon dioxide diagram
    »ê¼ÒÀÌ»êȭź¼ÒµµÇ¥(ß«áÈì£ß«ûù÷©áÈÓñøú).
  • partial pressure of carbon dioxide
    ź»ê°¡½ººÐ¾Ð(̬Ë×ÊÙËÓËâ).
  • partial pressure of carbon dioxide
    ź»ê°¡½ººÐ¾Ð(÷©ß«¡­ÝÂäâ).
  • primary yolk sac [primary vitellin sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac [primary vitelline sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac[primary vitelline sac]
  • primary yolk sac[primary vitelline sac]
  • dioxide
    ÀÌ»êÈ­¹°(ì£ß«ûùÚª).
  • manganese dioxide
    ÀÌ»êÈ­¸Á°£.
  • molybdenum dioxide
    ÀÌ»êÈ­(ì£ß«ûù)¹°¸®ºê µ§.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
  • Primary cephalic vein
    ÀÏÂ÷¸Ó¸®Á¤¸Æ
    [¿¾ ¿ë¾î] ÀÏÂ÷µÎÁ¤¸Æ
  • Primary capillary network
    ÀÏÂ÷¸ð¼¼Ç÷°ü±×¹°
    [¿¾ ¿ë¾î] ÀÏÂ÷¸ð¼¼Ç÷°ü¸Á
  • Primary abdominal implantation
    ÀÏÂ÷¹è¾ÈÂø»ó
    [¿¾ ¿ë¾î] ÀÏÂ÷Àûº¹ºÎÂø»ó
  • Primary bone
    ÀÏÂ÷»À
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ
  • Primary osteon
    ÀÏÂ÷»À´ÜÀ§
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¿ø
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý·Ú
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÇü¼º¾Æ
  • Primary ossification center
    ÀÏÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary ossification center [Diaphyseal ossification center]
    ÀÏÂ÷»À¹ß»ýÁ᫐ [»À¸öÅë¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary bone trabecula
    ÀÏÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ÒÁÖ
  • Primary trilaminar cortex
    ÀÏÂ÷»ïÃþÆÇ°ÑÁú
    [¿¾ ¿ë¾î] ÀÏÂ÷»ïÃþÆÇÇÇÁú
  • Primary nodule
    ÀÏÂ÷¼ÒÀý
    [¿¾ ¿ë¾î] ÀÏÂ÷¼ÒÀý
  • Primary bud
    ÀÏÂ÷½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷·Ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary acidosis
    ¿ø¹ß¼º »êÁõ(ê«Û¡àõß«ñø)
  • primary active transport
    ÀÏÂ÷ ´Éµ¿¼ö¼Û(ìéó­ÒöÔÑâÃáê)
  • primary alkali deficit
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®°áÇÌ(ÌÀù¹)
  • primary alkalosis
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®Áõ(ñø)
  • primary amino acid
    ÀÏÂ÷(ìéó­) ¾Æ¹Ì³ë»ê(ß«)
  • primary bile acid
    ÀÏÂ÷ ´ãÁó»ê(ìéó­ÓÅñðß«)
  • primary charge effect
    ÀÏÂ÷ ÀüÇÏÈ¿°ú(ìéó­ï³ùÃüùÍý)
  • primary culture
    ÀÏÂ÷ ¹è¾ç(ìéó­ÛÆå×)
  • primary deficiency
    ¿ø¹ß¼º °áÇÌ(ê«Û¡àõÌÀù¹)
  • primary derived protein
    ÀÏÂ÷ À¯µµ ´Ü¹éÁú(ìéó­ë¯ÓôÓ±ÛÜòõ)
  • primary filament
    ÀÏÂ÷(ìéó­) Çʶó¸àÆ®
  • primary fluor
    ÀÏÂ÷ Çü±¤Ã¼(ìéó­û«ÎÃô÷)
  • primary immune response
    ÀÏÂ÷ ¸é¿ª´ëÀÀ(ìéó­Øóæ¹Óßëë)
  • primary ionization
    ÀÏÂ÷(ìéó­) ÀÌ¿ÂÈ­(ûù)
  • primary isotope effect
    ÀÏÂ÷ µ¿À§¿ø¼Ò È¿°ú(ìéó­ÔÒêÈêªáÈüùÍý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary ossification center
    ÀÏÂ÷°ñÈ­Áß½É
  • primary ray
    ÀÏÂ÷¼±
  • primary tuberculosis
    ÀÏÂ÷°áÇÙ(Áõ), Ãʱâ°áÇÙ(Áõ)
  • primary tumor
    ¿ù¹ßÁ¾¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CO2 carbon dioxide
ctCO2 carbon dioxide concentration
DCCO2 diffusing capacity for carbon dioxide
DLCO2 carbon dioxide diffusion in the lungs
ECCO2R extracorporeal carbon dioxide removal
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SC-CO2 Supercritical carbon dioxide
PCO2 pressure , carbon dioxide pressure
PACO2 pressure of arterial carbon dioxide
primary SS Primary Sjogren's syndrome
NO2 Nitrogen Dioxide
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • excess water
    À׿© ¼öºÐ
  • manganese dioxide
    ÀÌ»êÈ­ ¸Á°£
  • molybdenum dioxide
    ÀÌ»êÈ­ ¸ô¸®ºêµ§
  • silicon dioxide colloidal
    ÄÝ·ÎÀ̵å»ó ÀÌ»êÈ­ ±Ô¼Ò
    ±Ô¼Ò È­ÇÕ¹°ÀÇ °¡¼öºÐÇØ¿¡ ÀÇÇØ¼­ ¸¸µé¾îÁø ÃÊÇö¹Ì°æÀû ¿¬¹«È­ ½Ç¸®Ä«·Î¼­, Á¤Á¦ Èñ¼®Á¦, ÇöŹȭÁ¦, ³óÁ¶È­Á¦·Î »ç¿ëµÈ´Ù.
  • sulfur dioxide control
    ÀÌ»êÈ­ Ȳ °¡½º ±ÔÁ¦
  • zone of antigen excess
    Ç׿ø °úÀ×´ë
    ºñ±³Àû °í³óµµÀÇ Ç׿ø´ë·Î¼­ ħ°­¹ÝÀÀ¿¡¼­ °¡¿ë¼º º¹ÇÕü°¡ Çü¼ºµÇ¸ç ¹ÝÀÀÀÌ ¾ïÁ¦µÈ´Ù.
  • asymmetric carbon atom
    ºñ´ëĪ ź¼Ò ¿øÀÚ
  • asymmetrical carbon atom
    ºñ´ëĪ ź¼Ò ¿øÀÚ
  • carbon
    ź¼Ò
    ºñ±Ý¼Ó 4°¡ ¿ø¼Ò. °ÅÀÇ ¼ø¼öÇÑ ÇüÀ¸·Î´Â ´ÙÀ̾Ƹóµå¿¡ Á¸ÀçÇϰí, ´ë·« ¼ø¼öÇÑ ÇüÀ¸·Î´Â ź, Èæ¿¬, ¹«¿¬Åº¿¡ ÀÖ´Ù. ¿ø¼Ò±âÈ£ C, ¿øÀÚ¹øÈ£ 6, ¿øÀÚ·® 12.011.
  • carbon arc phototherapy
    Ä«º» ¾ÆÅ© ±¤¿ä¹ý
  • carbon are phototherapy
    ź¼Ò ¾ÆÅ© ±¤¼± ¿ä¹ý
  • carbon coating
    ź¼Ò ÇǺ¹ °¡°ø
  • carbon disulfide poisoning
    ÀÌȲȭ ź¼Ò Áßµ¶
    ÀÌȲȭ ź¼Ò¿¡ ³ëÃâµÇ¾î »ý±â´Â Àü½Å ¼è¾à, ºÒ¸é, ½Ã·Â Àå¾Ö¸¦ Ư¡À¸·Î ÇÏ´Â Áßµ¶ Áõ¼¼.
  • carbon monoxide
    ÀÏ»êÈ­ ź¼Ò
    ¹«»ö À¯µ¶¼ºÀÇ ±âü. CO, ź¼Ò ¶Ç´Â À¯±â ¿¬·á¸¦ »ê¼Ò ºÎÁ· »óÅ¿¡¼­ ¿¬¼Ò½ÃŰ¸é ¹ß»ýÇÑ´Ù. Ç÷»ö¼Ò¿Í ºÒ°¡¿ªÀûÀ¸·Î °áÇÕÇÏ¿© Áú½ÄÀ» ÀÏÀ¸Å²´Ù.
  • carbon monoxide poisoning
    ÀÏ»êÈ­ ź¼Ò Áßµ¶
    ÀÏ»êÈ­ ź¼Ò¸¦ ÈíÀÔÇÔÀ¸·Î½á ÀϾ´Â Áßµ¶Áõ¼¼. ÀÏ»êÈ­ ź¼Ò´Â ź¼Ò¸¦ ÇÔÀ¯ÇÑ À¯±â¹°ÀÌ ºÒ¿ÏÀü ¿¬¼ÒÇÒ ¶§ ¹ß»ýÇÑ´Ù. µû¶ó¼­ Á¦Ã¶, µµ½Ã°¡½º Á¦Á¶, °¡Á¤¿¡¼­ ¹ß»ýÇϸç ÀÚµ¿Â÷ ¹è±â °¡½º¿¡µµ Æ÷ÇԵǾî ÀÖ°í °¡Á¤¿¡¼­ ¿¬·áÀÇ ¿¬¼Ò¿¡ ÀÇÇØ¼­µµ »ý±ä´Ù. ÀÏ»êÈ­ ź¼Ò¸¦ ÈíÀÔÇÏ¸é Æó¿¡¼­ Ç÷¾× ¼ÓÀÇ Çì¸ð±Û·Îºó°ú °áÇÕÇÏ¿© ÀÏ»êÈ­ ź¼Ò Çì¸ð±Û·ÎºóÀ» Çü¼ºÇϰí, ÀÌ ¶§¹®¿¡ Ç÷¾×ÀÇ »ê¼Ò ¿î¹Ý ´É·ÂÀÌ »ó½ÇµÇ¾î ³»ºÎÀûÀÎ Áú½Ä »óÅ¿¡ ºüÁö°Ô µÈ´Ù. ÀÏ»êÈ­ ź¼Ò¿Í Çì¸ð±Û·Îºó°úÀÇ Ä£È­¼ºÀº ±ØÈ÷ °­ÇÏ¿© »ê¼Òº¸´Ù 250¹èÀÇ ¼¼±â·Î °áÇÕÇÑ´Ù. »ç¶÷¿¡ µû¶ó ÀÏ»êÈ­ ź¼Ò¿¡ ´ëÇÑ °¨¼ö¼ºÀÌ ´Ù¸£Áö¸¸, °ø±â ¼Ó¿¡ 0.001 %¸¸ µé¾î À־ Áßµ¶À» ÀÏÀ¸Å²´Ù. ¶Ç 0.06 %¿¡¼­´Â 1½Ã°£¸¸ ÈíÀÔÇÏ¸é µÎÅëÀ» ÀÏÀ¸Å°°í 2½Ã°£ÀÌ¸é ½Ç½ÅÇÑ´Ù. ¶Ç 0.1 %ÀÇ °æ¿ì´Â 1½Ã°£ À̳»¿¡ ½Ç½ÅÇϰí 4½Ã°£ÀÌ¸é »ç¸ÁÇÑ´Ù. Áßµ¶ Áõ¼¼´Â Á¶Á÷ÀÇ ¹«»ê¼ÒÁõ¿¡ ÀÇÇÑ °ÍÀ¸·Î¼­, ±Þ¼º Áßµ¶Àº ±Þ°ÝÈ÷ »ç¸ÁÇÏ´Â ¼öµµ ÀÖÁö¸¸, ´ë°³´Â óÀ½¿¡ µÎÅë, Çö±âÁõ, À̸í, ±¸¿ªÁú, ±¸Åä µîÀÌ ÀÖ°í, »çÁöÀÇ ¿îµ¿ÀÌ ºÒ°¡´ÉÇÏ°Ô µÇ¸ç, ´Ù¼ÒÀÇ ÀǽÄÀÌ ³²¾Æ À־ ±×´ë·Î Á×À½¿¡ À̸£°Ô µÈ´Ù. Ÿ°¢ÀûÀ¸·Î´Â ¾È¸é¿¡ È«Á¶¸¦ ¶ì°í Àü½Å¿¡ ¹«´Ì ¸ð¾çÀÇ ¹ßÀûÀÌ ³ªÅ¸³ª¸ç, È£ÈíÀÌ °¡´Ã°í ºÒ±ÔÄ¢ÇÏ°Ô µÈ´Ù. ÄÚ¸¦ °ñ°í ü¿ÂÀÌ ³»·Á°¡°í Àü½ÅÀÇ ±ÙÀ° ÀÌ¿Ï µîÀÌ º¸À̸ç, È£Èí°ï¶õÀÇ Áõ¼¼°¡ º¸ÀÌÁö ¾Ê´Â Áß¿¡ È£ÈíÀÌ Á¤ÁöÇÏ°Ô µÈ´Ù. ´ÙÇàÈ÷ »ý¸íÀ» °ÇÁø °æ¿ì¿¡µµ ÈÄÀ¯ÁõÀÌ ³²´Âµ¥, ±× Áõ¼¼·Î´Â µÎÅë, Çö±âÁõ, ±Ù¹«·ÂÁõ, ºÒ¸é, ¿À½ÉÀ» ºñ·ÔÇÏ¿© ±â¾ï·Â, ½Ã·Â, û·Â, ¾ð¾îÀå¾Ö, ºÒ¼öÀÇ ¿îµ¿, ¸¶ºñ µîÀÌ ³ªÅ¸³­´Ù. Ä¡·á·Î¼­´Â µÉ¼ö·Ï »¡¸® ½Å¼±ÇÑ °ø±â ¼ÓÀ¸·Î ¿Å±â°í, Àΰø È£ÈíÀ̳ª »ê¼Ò ÈíÀÔ µîÀ» Çϰí Àý´ë ¾ÈÁ¤À» ½ÃŲ´Ù. »ê¼Ò ÈíÀÔ¿¡´Â 95 %ÀÇ »ê¼Ò¿¡ 5 %ÀÇ Åº»ê °¡½º¸¦ È¥ÇÕÇϸé È£Èí ÁßÃ߸¦ ÀÚ±ØÇϰí, ¶Ç´Â »ê¼º ¹ÝÀÀ¿¡¼­´Â ÀÏ»êÈ­ ź¼Ò°¡ ºÒ¾ÈÁ¤ÇØÁ® ¹èÃâµÇ±â ½¬¿öÁø´Ù. ±×¹Û¿¡ ȣȩ ÀÚ±ØÁ¦¸¦ ÁÖ»çÇϰųª, »çÇ÷ÇÑ ´ÙÀ½ ¼öÇ÷ ¶Ç´Â Æ÷µµ´ç ¾×, ¸µ°Å ¾× µîÀ» ÁÖÀÔÇϰí, ¶Ç °­½ÉÁ¦ µîÀ» Åõ¿©Çϱ⵵ ÇÑ´Ù. ¸¸¼º Áßµ¶Àº ±ØÈ÷ ¹Ì·®ÀÇ ÀÏ»êÈ­ ź¼Ò¸¦ ¹Ýº¹ÇÏ¿© ÈíÀÔÇÑ °á°ú ÀϾ´Â °ÍÀ¸·Î¼­, ±Þ¼º Áßµ¶ÀÇ ÈÄÀ¯Áõ°ú ºñ½ÁÇÑ Áõ¼¼¸¦ ³ªÅ¸³½´Ù. Áï, µÎÅë, ±Çۨ, ±â¾ï·Â °¨Åð, Çö±âÁõ, ºÒ¸éÁõ, ¾ð¾îÀå¾Ö, ºóÇ÷, Ȳ´Þ, ±¸Åä µîÀÇ Áõ¼¼°¡ º¸À̰í, ¶§·Î´Â ±Þ¼º ½É ¼è¾à¿¡ ºüÁ® Á×´Â Àϵµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
anaemia, refractory, with excess of blasts Chronic refractory anaemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.
(12 Dec 1998)
antibody excess In a precipitation test, the presence of antibody in an amount greater than that required to combine with all of the antigen present.
(05 Mar 2000)
antigen excess In a precipitation test, the presence of uncombined antigen above that required to combine with all of the antibody; precipitation may be inhibited because the presence of excess antigen gives rise to soluble antigen-antibody complexes, in vivo the resultant antigen-antibody interaction in such an antigen excess may give rise to immune complexes, which have a potential to induce cellular damage; such injury underlies the pathologic changes seen in certain immune complex diseases.
(05 Mar 2000)
base excess A measure of metabolic alkalosis, usually predicted from the Siggaard-Andersen nomogram; the amount of strong acid that would have to be added per unit volume of whole blood to titrate it to pH 7.4 while at 37°C and at a carbon dioxide pressure of 40 mm Hg.
(05 Mar 2000)
calcium excess Overly high intake of calcium (hypercalcaemia) may cause muscle weakness and constipation, affect the conduction of electrical impulses in the heart (heart block) lead to calcium stones in the urinary tract, impair kidney function (through nephrocalcinosis), and interfere with the absorption of iron predisposing to iron deficiency. According to the National Academy of Sciences, adequate intake of calcium is 1 gram daily for both men and women. The upper limit for calcium intake is 2.5 grams daily.
(12 Dec 1998)
magnesium excess Persons with impaired kidney function should be especially careful about their magnesium intake because they can accumulate magnesium, a dangerous situation. According to the national academy of sciences, the recommended dietary allowances of magnesium are 420 milligrams per day for men and 320 milligrams per day for women. The upper limit of magnesium as supplements is 350 milligrams daily, in addition to the magnesium from food and water.
(12 Dec 1998)
refractory anaemia with excess blasts <haematology> A form of myelodysplasia characterised by the build up of immature white blood cells (blasts) in the bone marrow.
If the immature cells are particularly numerous it may indicate a chance of transformation to acute leukaemia and the condition is called refractory anaemia with excess blasts in transformation (RAEBt).
Acronym: RAEB
(13 Nov 1997)
convergence excess That condition in which an oesophoria or esotropia is greater for near vision than for far vision.
(05 Mar 2000)
selenium excess Too much of the mineral selenium may cause reversible changes in the hair (balding) and nails, garlic odour to the breath, intestinal distress, weakness and slower mentation (slowed mental functionning). According to the national academy of sciences, the recommended dietary allowances of selenium are 70 milligrams per day for men and 55 milligrams per day for women.
(12 Dec 1998)
negative base excess A measure of metabolic acidosis, usually predicted from the Siggaard-Andersen nomogram; the amount of strong alkali that would have to be added per unit volume of whole blood to titrate it to pH 7.4 while at 37°C and at a carbon dioxide pressure of 40 mm Hg.
(05 Mar 2000)
divergence excess exotropia Exotropia in which the strabismus is notably greater for far vision than for near vision.
(05 Mar 2000)
iodine excess Just as too little iodine can cause thyroid disease, so may prolonged intake of too much iodine also lead to the development of goiter (swelling of the thyroid gland) and hypothyroidism (abnormally low thyroid activity). Certain foods and medications contain large amounts of iodine. Examples include seaweed; iodine-rich expectorants (such as sski and lugol's solution) used in the treatment of cough, asthma, chronic pulmonary disease; and amiodarone (cardorone), an iodine-rich medication used in the control of abnormal heart rhythms (cardiac arrhythmias).
(12 Dec 1998)
iron excess Iron overload can damage the heart, liver, gonads and other organs. Iron overload is a particular risk in people who may have certain genetic conditions (haemochromatosis) sometimes without knowing it and also in people receiving recurrent blood transfusions. According to the national academy of sciences, the recommended dietary allowances of iron are 15 milligrams per day for women and 10 milligrams per day for men.
(12 Dec 1998)
excess 1. The state of surpassing or going beyond limits; the being of a measure beyond sufficiency, necessity, or duty; that which exceeds what is usual or prover; immoderateness; superfluity; superabundance; extravagance; as, an excess of provisions or of light. "To gild refined gold, to paint the lily, To throw a perfume on the violet, . . . Is wasteful and ridiculous excess." (Shak) "That kills me with excess of grief, this with excess of joy." (Walsh)
2. An undue indulgence of the appetite; transgression of proper moderation in natural gratifications; intemperance; dissipation. "Be not drunk with wine, wherein is excess." (Eph. V. 18) "Thy desire . . . Leads to no excess That reaches blame." (Milton)
3. The degree or amount by which one thing or number exceeds another; remainder; as, the difference between two numbers is the excess of one over the other.
<geometry> Spherical excess, the amount by which the sum of the three angles of a spherical triangle exceeds two right angles. The spherical excess is proportional to the area of the triangle.
Origin: OE. Exces, excess, ecstasy, L. Excessus a going out, loss of self-possession, fr. Excedere, excessum, to go out, go beyond: cf. F. Exces. See Exceed.
Source: Websters Dictionary
(01 Mar 1998)
excess annual growth The amount by which new forest growth exceeds removal in a year. The annual quantity of wood produced in a forest in excess of market demand.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • carbon
    ź¼Ò(±âÈ£ C,¹øÈ£ 6);ź¼ÒºÀ;Ä«º»Áö;Ä«º»Áö¸¦ ¾´ »çº»
  • carbon 14
    ź¼Ò 14(ź¼ÒÀÇ ¹æ»ç¼º µ¿À§ ¿ø¼Ò,±âÈ£ C14)
  • carbon black
    Ä«º»ºí·¢(ÀμâÀ×Å©¿ø·á)
  • carbon copy
    Ä«º»Áö¿¡ ÀÇÇÑ º¹»ç;²À ´àÀº »ç¶÷(°Í);ÆÇ¹ÚÀÌ;²À °°Àº;º¹»çÇÏ´Ù;»çº»À» ¶ß´Ù
  • carbon cycle
    (»ý¹°±Ç)ÀÇ Åº¼Ò¼øÈ¯;ź¼Ò »çÀÌŬ
  • carbon dating
    ¹æ»ç¼º ź¼Ò ¿¬´ë ÃøÁ¤¹ý
  • carbon diamond
    =CARBONADO
  • carbon fiber
    ź¼Ò ¼¶À¯
  • carbon knock
    (¿£ÁøÀÇ)ºÒ¿ÏÀü ¿¬¼Ò·Î »ý±â´Â ³ëÅ© ¼Ò¸®
  • carbon monoxide
    ÀÏ»êȭź¼Ò
  • carbon paper
    Ä«º»Áö(º¹»ç¿ë)
  • carbon pile
    ź¼Ò ¿øÀÚ·Î
  • carbon process
    (printing)Ä«º»ÀÎÈ­¹ý
  • carbon steel
    ź¼Ò°­
  • carbon tetrachloride
    4¿°È­Åº¼Ò(µå¶óÀÌŬ¸®´× ¾àǰ.¼ÒÈ­Á¦)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á